Situations when the measurement of the DOAC anticoagulant effect is potentially useful and others that would require consideration
| Potentially useful . | Others . |
|---|---|
| At baseline (before initiation of treatment) | When chronic anticoagulation is achieved (1-2 weeks after initiation) |
| Before surgical or invasive procedures | During clinical visits |
| During adverse events (hemorrhage or thrombosis) | Soon before and after introducing additional drugs |
| Need for immediate reversal of anticoagulation | Low or high body weight |
| Potentially useful . | Others . |
|---|---|
| At baseline (before initiation of treatment) | When chronic anticoagulation is achieved (1-2 weeks after initiation) |
| Before surgical or invasive procedures | During clinical visits |
| During adverse events (hemorrhage or thrombosis) | Soon before and after introducing additional drugs |
| Need for immediate reversal of anticoagulation | Low or high body weight |